|
Published: November 08, 2025
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides
American Heart Association Scientific Sessions 2025, Abstract 4392851
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.